IEM 1754 dihydrobromide is a selective AMPA/kainate receptor antagonist that inhibits GluR1- and GluR3-containing receptors with an IC50 of 6 μM; it acts as a use- and voltage-dependent open-channel blocker of recombinant AMPA receptors, showing higher sensitivity in GluR1- and GluR3-gated channels compared to GluR2-containing receptors.